Evidence map›Paper›PMID 35612768›Full record

ArticleClinical rheumatology2022

Clinical evolution of antisynthetase syndrome after SARS-CoV2 infection: a 6-month follow-up analysis.

Valentina Vertui, Giovanni Zanframundo, Santos Castañeda, Alessandro Biglia, Bianca Lucia Palermo, Ilaria Cavazzana, Federica Meloni, Lorenzo Cavagna

Open access · bronzeAbstract readLetter
In one paragraph

Article in Clinical rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Valentina Vertui *Division of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy. valentina.vertui@gmail.com.ORCID http://orcid.org/0000-0002-6933-3220
Giovanni Zanframundo *Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Lombardia, Italy.ORCID https://orcid.org/0000-0001-5042-1282
Santos CastañedaRheumatology Division, Hospital de La Princesa, c/ Diego de León 62, IIS-IP, Madrid, Spain.ORCID https://orcid.org/0000-0002-7748-853X
Alessandro BigliaDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Lombardia, Italy.ORCID https://orcid.org/0000-0001-6006-678X
Bianca Lucia PalermoDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Lombardia, Italy.
Ilaria CavazzanaRheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, Italy.ORCID https://orcid.org/0000-0002-2757-7120
Federica MeloniDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Lombardia, Italy.ORCID https://orcid.org/0000-0003-4014-0617
Lorenzo CavagnaDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Lombardia, Italy.ORCID https://orcid.org/0000-0003-3292-1528
University of Pavia · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITHospital Universitario de La Princesa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Follow-Up StudiesHumansMyositisRNA, ViralSARS-CoV-2RNA, Viral

Identifiers

PMID35612768
PMCPMC9130053
OpenAlexW4281482172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.